تأسست شركة فار بايوتكنولوجي (Vir Biotechnology) في عام 2016 ويقع مقرها الرئيسي في سان فرانسيسكو، كاليفورنيا. هي شركة متخصصة في تطوير علم المناعة في المرحلة السريرية. تركز على علاج الأمراض المعدية والوقاية منها. تتداول فابايوتكنولوجي (Vir Biotechnology) في بورصة ناسداك تحت الرمز VIR. لا تترد في إضافة... عرض المزيد
Dear Investors,
Here is your monthly update for April 2022.
Financial markets struggled across the board in April as the continuing Russia-Ukraine conflict, as well as fears over more aggressive central bank interventions, weighed down markets.
Find out more about what happened in April with eToro's... عرض المزيد ترجم
$VIR (Vir Biotechnology Inc) Vir Biotechnology (NASDAQ:VIR) announced its quarterly results after the market closed on Thursday, May 5th. The company reported $3.85 earnings per share (EPS) for the previous quarter, beating the consensus estimate of $3.78 EPS by $0.07. The company had revenue of $1.20... عرض المزيد ترجم
$VIR (Vir Biotechnology Inc) Vir Biotechnology, Inc. (NASDAQ:VIR) Director Vicki L. Sato sold 17,915 shares of the company's stock in a transaction that occurred on Thursday, April 28th. The shares were sold at an average price of $20.90, for a total transaction of $374,423.50. Following the completion... عرض المزيد ترجم
